Himension Capital (Singapore)’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.51M	Sell	429,540 -149,022	-26%	-$1.9M	0.42%	33
2025 Q4	$5.2M	Buy	578,562 +13,432	+2%	+$185K	0.32%	32
2025 Q3	$9.76M	Sell	565,130 -164,291	-23%	-$2.02M	0.6%	24
2025 Q2	$6.84M	Sell	729,421 -23,255	-3%	-$191K	0.53%	24
2025 Q1	$5.35M	Sell	752,676 -233,039	-24%	-$2.35M	0.46%	24
2024 Q4	$11.5M	Sell	985,715 -89,996	-8%	-$1.4M	0.8%	16
2024 Q3	$22.1M	Buy	1,075,711 +45,729	+4%	+$1.05M	1.73%	11
2024 Q2	$23.1M	Sell	1,029,982 -639	-0.1%	-$15.2K	1.63%	12
2024 Q1	$28.4M	Hold	1,030,621	–	–	2.13%	7
2023 Q4	$31.4M	Sell	1,030,621 -114,470	-10%	-$3.29M	2.85%	9
2023 Q3	$36.2M	Hold	1,145,091	–	–	3.72%	7
2023 Q2	$46.7M	Hold	1,145,091	–	–	4.26%	7
2023 Q1	$42.7M	Hold	1,145,091	–	–	3.83%	6
2022 Q4	$40M	Sell	1,145,091 -46,102	-4%	-$2.19M	5.34%	7
2022 Q3	$66.7M	Sell	1,191,193 -25,147	-2%	-$1.56M	7.07%	6
2022 Q2	$63M	Buy	1,216,340 +472,180	+63%	+$24M	7.04%	8
2022 Q1	$54.1M	Buy	744,160 +153,920	+26%	+$13M	5.79%	9
2021 Q4	$69.8M	Buy	590,240 +169,381	+40%	+$21.2M	5.34%	7
2021 Q3	$56.5M	Buy	420,859 +120,532	+40%	+$18.2M	4.4%	7
2021 Q2	$48.6M	Buy	300,327 +277,207	+1,199%	+$21.6M	4.72%	6
2021 Q1	$1.85M	Buy	+23,120	New	+$1.55M	0.4%	13